v3.24.2.u1
Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Operating expenses:        
Research and development $ 4,360 $ 10,836 $ 8,164 $ 24,836
Asset impairment 2,649 0 2,649 0
General and administrative 1,531 3,055 2,958 5,376
Total operating expenses 8,540 13,891 13,771 30,212
Loss from operations (8,540) (13,891) (13,771) (30,212)
Other income (expense)        
Other income 314 429 314 780
Interest income 29 159 70 612
Interest expense (2) (2,932) (3) (4,108)
Total other income (expense) 341 (2,344) 381 (2,716)
Net Loss $ (8,199) $ (16,235) $ (13,390) $ (32,928)
Net loss per common share outstanding, basic $ (0.35) $ (2.00) $ (0.78) $ (4.06)
Net loss per common share outstanding, diluted $ (0.35) $ (2.00) $ (0.78) $ (4.06)
Weighted average number of common shares outstanding, basic 23,123,178 8,127,473 17,090,705 8,110,661
Weighted average number of common shares outstanding, diluted 23,123,178 8,127,473 17,090,705 8,110,661

Source